Fasnall HCl
Fasnall HCl is a selective fatty acid synthase (FASN) inhibitor that targets the enzyme's co-factor binding sites. It demonstrates significant anti-tumor efficacy in preclinical models, including the MMTV-Neu mouse model of HER2-positive breast cancer, particularly in combination with carboplatin. This small molecule is a valuable research tool for studying lipid metabolism in oncology.
Product Specifications
Product Name Alternative
929978-58-5, 929978-58-5 Free base, FattyAcidSynthase, Fatty Acid Synthase (FASN), Fatty Acid Synthase, Fasnall HCl, Fasnall HCl (929978-58-5 Free base)
Field of Research
Metabolism Research
Purity
90.00% (May vary between batches)
Solubility
DMSO:22.5 mg/mL (60.01 mM)
Smiles
CC1=C (C) SC2=NC=NC (NC3CN (CC3) CC4=CC=CC=C4) =C21.Cl
Molecular Formula
C19H23ClN4S
Molecular Weight
374.93
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC400525-500 1x 500 µL
CD63 (MX-49.129.5), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC682216-100 1x 100 µL
CD50 / ICAM3 (CG106), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC880745-100 1x 100 µL
CD45 / LCA (2B11 + PD7/26), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 